EZH2-IN-9 is a potent inhibitor of EZH2, which, through overexpression or mutations in the SET region (Y641F, Y641N, A687V, A677G point mutations), causes abnormal elevations in H3K27me3 and contributes to the growth and development of various tumours (e.g., breast cancer, prostate cancer, leukaemia). EZH2-IN-9 has shown potential for cancer research.
Molecular Weight:
596.09
CAS Number:
[2700897-24-9]
Formula:
C28H32ClF2N3O5S
Target:
Histone Methyltransferase|||Others
T64208
* VAT and and shipping costs not included. Errors and price changes excepted
